Back
Ampio Pharmaceuticals 10K Form
Sell
12
AMPE
Ampio Pharmaceuticals
Last Price:
0.26
Seasonality Move:
-7.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMPE News And Ratings
See the #1 stock for the next 7 days that we like better than AMPE
AMPE Financial Statistics
Sales & Book Value
Annual Sales: | $50K |
---|---|
Cash Flow: | $-2.31M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.03 |
Price / Book: | 0.09 |
Profitability
EPS (TTM): | -11.01000 |
---|---|
Net Income (TTM): | $-8.63M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Ampio Pharmaceuticals Earnings Forecast
Key Ampio Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for AMPE have been equal to 14,954.00% of Gross Profit Margin.
- The Interest Expense is -0.05% of Operating Income.
- Per Share Earnings over the last 18 years have been positive in 7 years.
Ampio Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Current Symbol: | AMPE |
CUSIP: | 03209T |
Website: | ampiopharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
AMPE Technical Analysis vs Fundamental Analysis
Sell
12
Ampio Pharmaceuticals (AMPE)
is a Sell
Is Ampio Pharmaceuticals a Buy or a Sell?
-
Ampio Pharmaceuticals stock is rated a Sell
The current Ampio Pharmaceuticals [AMPE] share price is $0.25. The Score for AMPE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.